ABT-436
id:
abt-436-239-13030374
title:
ABT-436
text:
ABT-436 is an orally active, highly selective vasopressin V1B receptor antagonist which was under development by Abbott Laboratories and AbbVie for the treatment of major depressive disorder, anxiety disorders, and alcoholism but was discontinued. It reached phase II clinical trials prior to the discontinuation of its development.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/ABT-436
date created:
date modified:
2024-03-15T21:04:20Z
main entity:
{"identifier":"Q30315186","url":"https://www.wikidata.org/entity/Q30315186"}
image:
fields total:
13
integrity:
14